Skip to main content
. 2017 Aug 14;25:78. doi: 10.1186/s13049-017-0425-6

Table 1.

General characteristics and treatments of patients presenting an upper gastrointestinal bleeding (UGB)

Arrival at the ED
n = 170
Pre-hospital management
n = 24
Total
n = 194
P value
Age (median [Q1–Q3])a 66 [49–82] 71 [57.5–75.5] 66 [51–81] 0.71
Sex (men; n, %) 88 (52) 17 (71) 105 (54) 0.085
Initial symptoms suggesting UGB, n (%) Hematemesis 87 (51) 17 (71) 104 (54) 0.096
Melena 70 (41) 5 (21) 75 (39)
Hematochezia 6 (4) 2 (8) 8 (4)
Other 7 (4) 0 (0) 7 (4)
Medical history and medication, n (%)b n = 143 n = 20 n = 163
 Known cirrhosis 31 (22) 4 (20) 35 (21) 1.
 Known ulcer 33 (23) 5 (25) 38 (23) 0.78
 Non-steroid anti-inflammatory drugs 10 (7) 2 (10) 12 (7) 0.64
 Antithrombotic agents 54 (38) 8 (40) 62 (38) 1.
 Comorbidity 57 (40) 5 (25) 62 (38) 0.25
Exteriorized bleeding in the ED, n (%)c 86 (51) 16 (67) 102 (53) 0.19
Clinical features of severity, n (%)d n = 166 n = 22 n = 188
 Heart rate > 100 bpm 36 (22) 12 (55) 48 (26) 0.003
 Systolic arterial pressure < 90 mmHg 27 (16) 8 (36) 35 (19) 0.037
 Marbling 5 (3) 3 (14) 8 (4) 0.053
 Altered mental status 5 (3) 4 (18) 9 (5) 0.012
Hemoglobin level, n (%)e < 7 g/dL 34 (20) 5 (24) 39 (21) 0.77
Treatments in ED, n (%) n = 170 n = 24 n = 194
 Nasogastric tube 15 (9) 4 (17) 19 (10) 0.26
 Fluid administration 55 (32) 12 (50) 67 (35) 0.11
 Transfusion 71 (42) 1 (4) 72 (37) 0.0002
 Proton pump inhibitors 132 (78) 8 (33) 140 (72) < 0.0001
 Vasopressors 33 (19) 3 (13) 36 (19) 0.58
 Catecholamines 2 (1) 2 (8) 4 (2) 0.075
 Antibioticsf (excluding erythromycin) 8 (5) --- --- ---
 Vitamin K antagonist reversal 18 (11) 1 (4) 19 (10) 0.048
 Erythromycin 16 (9) 1 (4) 17 (9) 0.70

afor 193 of 194 patients

bfor 163 of 194 patients

cfor 192 of 194 patients

dfor 188 of 194 patients

efor 189 of 194 patients

ffor 170 of 194 patients